Target Healthcare REIT (LON:THRL) Reaches New 1-Year High – Should You Buy?

Target Healthcare REIT (LON:THRL)’s share price reached a new 52-week high on Friday . The stock traded as high as GBX 112 and last traded at GBX 110.60, with a volume of 557413 shares changing hands. The stock had previously closed at GBX 110.80.

Analysts Set New Price Targets

Separately, Jefferies Financial Group reaffirmed a “hold” rating and set a GBX 101 price objective on shares of Target Healthcare REIT in a report on Wednesday, May 6th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of GBX 101.

Target Healthcare REIT Stock Performance

The stock has a market capitalization of £682.26 million, a P/E ratio of 8.75, a price-to-earnings-growth ratio of 1.48 and a beta of 0.54. The firm has a 50-day moving average price of GBX 106.47 and a 200 day moving average price of GBX 103.81.

About Target Healthcare REIT

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.